Global Bipolar Disorder Market Size, Share, and COVID-19 Impact Analysis, By Type (Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, Others), By Drug Class (Mood Stabilizers, Anticonvulsants, Antipsychotic Drugs, Antidepressant Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Industry: Healthcare
RELEASE DATE Jun 2024
REPORT ID SI4546
PAGES 207
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Type
      2. Market Attractiveness Analysis, By Drug Class
      3. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Growing public awareness regarding bipolar disease.
    3. Restraints
      1. lack of useful diagnostic tools.
    4. Opportunities
      1. Rising government support
    5. Challenges
      1. Misdiagnosis of bipolar disorder
  6. Global Bipolar Disorder Market Analysis and Projection, By Type
    1. Segment Overview
    2. Bipolar I Disorder
    3. Bipolar II Disorder
    4. Cyclothymic Disorder
    5. Others
  7. Global Bipolar Disorder Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2. Mood Stabilizers
    3. Anticonvulsants
    4. Antipsychotic Drugs
    5. Antidepressant Drugs
  8. Global Bipolar Disorder Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Bipolar Disorder Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Bipolar Disorder Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Bristol Myers Squibb Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  GlaxoSmithKline plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   H. Lundbeck A/S
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Janssen Pharmaceuticals Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Otsuka Holdings Co. Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.  Pfizer Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Sunovion Pharmaceuticals Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Teva Pharmaceutical Industries Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Takeda Pharmaceutical Company Limited
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Abbott Laboratories
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Novartis International AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  Alkermes plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  AbbVie Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Merck & Co. Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    16. Mylan N.V.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    17. Neurocrine Biosciences Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    18. Vanda Pharmaceuticals Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    19. Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Bipolar Disorder Market, By Type, 2023-203(USD Billion)
  2. Global Bipolar I Disorder, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  3. Global Bipolar II Disorder, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  4. Global Cyclothymic Disorder, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  5. Global Others, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  6. Global Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  7. Global Mood Stabilizer, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  8. Global Anticonvulsants, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  9. Global Antipsychotic Drugs, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  10. Global Antidepressant Drugs, Bipolar Disorder Market, By Region, 2023-2033(USD Billion)
  11. North America Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  12. North America Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  13. U.S.  Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  14. U.S.  Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  15. Canada Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  16. Canada Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  17. Mexico Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  18. Mexico Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  19. Europe Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  20. Europe Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  21. Germany Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  22. Germany Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  23. France Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  24. France Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  25. U.K.  Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  26. U.K.  Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  27. Italy Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  28. Italy Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  29. Spain Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  30. Spain Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  31. Asia Pacific Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  32. Asia Pacific Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  33. Japan Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  34. Japan Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  35. China Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  36. China Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  37. India Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  38. India Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  39. South America Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  40. South America Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  41. Brazil Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  42. Brazil Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  43. The Middle East and Africa Bipolar Disorder Market, By Type, 2023-2033(USD   Billion)
  44. The Middle East and Africa Bipolar Disorder Market, By Drug Class, 2023-2033(USD   Billion)
  45. UAE Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  46. UAE Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)
  47. South Africa Bipolar Disorder Market, By Type, 2023-2033(USD Billion)
  48. South Africa Bipolar Disorder Market, By Drug Class, 2023-2033(USD Billion)

List of Figures 

  1. Global Bipolar Disorder Market Segmentation
  2. Bipolar Disorder Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Bipolar Disorder Market
  9. Top Winning Strategies, 2023-2033
  10. Top Winning Strategies, By Development, 2023-2033(%)
  11. Top Winning Strategies, By Company, 2023-2033
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2023
  18. Market Share Analysis, 2023
  19. Restraint and Drivers:  Bipolar Disorder Market
  20. Bipolar Disorder Market Segmentation, By Type
  21. Bipolar Disorder Market For Bipolar I Disorder, By Region, 2023-2033 ($ Billion)
  22.  Bipolar Disorder Market For Bipolar II Disorder, By Region, 2023-2033 ($ Billion)
  23. Bipolar Disorder Market For Cyclothymic Disorder, By Region, 2023-2033 ($ Billion)
  24. Bipolar Disorder Market For Others, By Region, 2023-2033 ($ Billion)
  25. Bipolar Disorder Market Segmentation, By Drug Class
  26. Bipolar Disorder Market For Mood Stabilizers, By Region, 2023-2033 ($ Billion)
  27. Bipolar Disorder Market For Anticonvulsants, By Region, 2023-2033 ($ Billion)
  28. Bipolar Disorder Market For Antipsychotic Drugs, By Region, 2023-2033 ($ Billion)
  29. Bipolar Disorder Market For Antidepressant Drugs, By Region, 2023-2033 ($ Billion)
  30. Bristol Myers Squibb Company: Net Sales, 2023-2033 ($ Billion)
  31. Bristol Myers Squibb Company: Revenue Share, By Segment, 2023 (%)
  32. Bristol Myers Squibb Company: Revenue Share, By Region, 2023 (%)
  33. Eli Lilly and Company: Net Sales, 2023-2033 ($ Billion)
  34. Eli Lilly and Company: Revenue Share, By Segment, 2023 (%)
  35. Eli Lilly and Company: Revenue Share, By Region, 2023 (%)
  36. GlaxoSmithKline plc: Net Sales, 2023-2033 ($ Billion)
  37. GlaxoSmithKline plc: Revenue Share, By Segment, 2023 (%)
  38. GlaxoSmithKline plc: Revenue Share, By Region, 2023 (%)
  39. H. Lundbeck A/S: Net Sales, 2023-2033 ($ Billion)
  40. H. Lundbeck A/S: Revenue Share, By Segment, 2023 (%)
  41. H. Lundbeck A/S: Revenue Share, By Region, 2023 (%)
  42. Janssen Pharmaceuticals Inc.: Net Sales, 2023-2033 ($ Billion)
  43. Janssen Pharmaceuticals Inc.: Revenue Share, By Segment, 2023 (%)
  44. Janssen Pharmaceuticals Inc.: Revenue Share, By Region, 2023 (%)
  45. Otsuka Holdings Co. Ltd.: Net Sales, 2023-2033 ($ Billion)
  46. Otsuka Holdings Co. Ltd.: Revenue Share, By Segment, 2023 (%)
  47. Otsuka Holdings Co. Ltd.: Revenue Share, By Region, 2023 (%)
  48. Pfizer Inc.: Net Sales, 2023-2033 ($ Billion)
  49. Pfizer Inc.: Revenue Share, By Segment, 2023 (%)
  50. Pfizer Inc.: Revenue Share, By Region, 2023 (%)
  51. Sunovion Pharmaceuticals Inc.: Net Sales, 2023-2033 ($ Billion)
  52. Sunovion Pharmaceuticals Inc.: Revenue Share, By Segment, 2023 (%)
  53. Sunovion Pharmaceuticals Inc.: Revenue Share, By Region, 2023 (%)
  54. Teva Pharmaceutical Industries Ltd..: Net Sales, 2023-2033 ($ Billion)
  55. Teva Pharmaceutical Industries Ltd..: Revenue Share, By Segment, 2023 (%)
  56. Teva Pharmaceutical Industries Ltd..: Revenue Share, By Region, 2023 (%)
  57. Takeda Pharmaceutical Company Limited: Net Sales, 2023-2033 ($ Billion)
  58. Takeda Pharmaceutical Company Limited: Revenue Share, By Segment, 2023 (%)
  59. Takeda Pharmaceutical Company Limited: Revenue Share, By Region, 2023 (%)
  60. Abbott Laboratories: Net Sales, 2023-2033 ($ Billion)
  61. Abbott Laboratories: Revenue Share, By Segment, 2023 (%)
  62. Abbott Laboratories: Revenue Share, By Region, 2023 (%)
  63. Novartis International AG: Net Sales, 2023-2033 ($ Billion)
  64. Novartis International AG: Revenue Share, By Segment, 2023 (%)
  65. Novartis International AG: Revenue Share, By Region, 2023 (%)
  66. Alkermes plc: Net Sales, 2023-2033 ($ Billion)
  67. Alkermes plc: Revenue Share, By Segment, 2023 (%)
  68. Alkermes plc: Revenue Share, By Region, 2023 (%)
  69. AbbVie Inc.: Net Sales, 2023-2033 ($ Billion)
  70. AbbVie Inc.: Revenue Share, By Segment, 2023 (%)
  71. AbbVie Inc.: Revenue Share, By Region, 2023 (%)
  72. Merck & Co. Inc.: Net Sales, 2023-2033 ($ Billion)
  73. Merck & Co. Inc.: Revenue Share, By Segment, 2023 (%)
  74. Merck & Co. Inc.: Revenue Share, By Region, 2023 (%)
  75. Mylan N.V.: Net Sales, 2023-2033 ($ Billion)
  76. Mylan N.V.: Revenue Share, By Segment, 2023 (%)
  77. Mylan N.V.: Revenue Share, By Region, 2023 (%)
  78. Neurocrine Biosciences Inc.: Net Sales, 2023-2033 ($ Billion)
  79. Neurocrine Biosciences Inc.: Revenue Share, By Segment, 2023 (%)
  80. Neurocrine Biosciences Inc.: Revenue Share, By Region, 2023 (%)
  81. Vanda Pharmaceuticals Inc.: Net Sales, 2023-2033 ($ Billion)
  82. Vanda Pharmaceuticals Inc.: Revenue Share, By Segment, 2023 (%)
  83. Vanda Pharmaceuticals Inc.: Revenue Share, By Region, 2023 (%)
  84. Others.: Net Sales, 2023-2033 ($ Billion)
  85. Others: Revenue Share, By Segment, 2023 (%)
  86. Others: Revenue Share, By Region, 2023 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2023
Tables & Figures:110
Pages:207
Countries covered:17
Companies covered::20
Forecast CAGR:1.98%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies